AJCN North Carolina Research Campus
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kilkkinen, A.
Right arrow Articles by Adlercreutz, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kilkkinen, A.
Right arrow Articles by Adlercreutz, H.
Agricola
Right arrow Articles by Kilkkinen, A.
Right arrow Articles by Adlercreutz, H.
American Journal of Clinical Nutrition, Vol. 73, No. 6, 1094-1100, June 2001
© 2001 American Society for Clinical Nutrition


Original Research Communication

Determinants of serum enterolactone concentration1,2,3

Annamari Kilkkinen, Katariina Stumpf, Pirjo Pietinen, Liisa M Valsta, Heli Tapanainen and Herman Adlercreutz

1 From the National Public Health Institute, Department of Epidemiology and Health Promotion, Helsinki, Finland; the Institute for Preventive Medicine, Nutrition, and Cancer, Folkhälsan Research Center, Helsinki, Finland; and the Department of Clinical Chemistry, University of Helsinki, Helsinki, Finland.

Background: The lignan enterolactone, which is produced by the intestinal microflora from dietary precursors, may protect against hormone-dependent cancers and cardiovascular diseases.

Objective: We examined the cross-sectional associations between the serum enterolactone concentration and variables related to diet and health in Finnish adults.

Design: Serum enterolactone was measured by using time-resolved fluoroimmunoassay in 2380 Finnish men and women aged 25–64 y who were participating in a cross-sectional national survey in 1997. Background information was collected with self-administered questionnaires and the diet was assessed with a food-frequency questionnaire.

Results: The median serum enterolactone concentration was 13.8 nmol/L (range: 0–95.6 nmol/L) in men and 16.6 nmol/L (range: 0–182.6 nmol/L) in women. Multiple regression analyses showed positive associations in men between the serum enterolactone concentration and constipation, consumption of whole-grain products, and intake of fruit and berries. In women, the serum enterolactone concentration was positively and independently associated with consumption of vegetables, subject age, and constipation and was negatively associated with smoking. Furthermore, female subjects of normal weight had significantly higher serum enterolactone concentrations than did their underweight or obese peers.

Conclusions: The serum enterolactone concentration varies widely in the population. Of the variables we examined, the most important determinants of the serum enterolactone concentration were consumption of lignan-containing foods and constipation; however, these appeared to explain only a small part of the variation. Therefore, the role of gut microflora in the metabolism of lignans might be very important. Further studies will also be needed to determine the bioavailability and absorption rate of lignans.

Key Words: Cross-sectional study • enterolactone • Finland • diet • lignans • phytoestrogens • cancer prevention • cardiovascular disease prevention • hormone-dependent cancers • intestinal microflora • gut microflora




This article has been cited by other articles:


Home page
Am J EpidemiolHome page
A. Kuijsten, P. C. H. Hollman, H. C. Boshuizen, M. N. C. P. Buijsman, P. van 't Veer, F. J. Kok, I. C. W. Arts, and H. B. Bueno-de-Mesquita
Plasma Enterolignan Concentrations and Colorectal Cancer Risk in a Nested Case-Control Study
Am. J. Epidemiol., March 15, 2008; 167(6): 734 - 742.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
C. Atkinson, K. M Newton, E. J A. Bowles, M. Yong, and J. W Lampe
Demographic, anthropometric, and lifestyle factors and dietary intakes in relation to daidzein-metabolizing phenotypes among premenopausal women in the United States
Am. J. Clinical Nutrition, March 1, 2008; 87(3): 679 - 687.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
P. Penttinen, J. Jaehrling, A. E. Damdimopoulos, J. Inzunza, J. G. Lemmen, P. van der Saag, K. Pettersson, G. Gauglitz, S. Makela, and I. Pongratz
Diet-Derived Polyphenol Metabolite Enterolactone Is a Tissue-Specific Estrogen Receptor Activator
Endocrinology, October 1, 2007; 148(10): 4875 - 4886.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
L.-H. Chen, J. Fang, H. Li, W. Demark-Wahnefried, and X. Lin
Enterolactone induces apoptosis in human prostate carcinoma LNCaP cells via a mitochondrial-mediated, caspase-dependent pathway
Mol. Cancer Ther., September 1, 2007; 6(9): 2581 - 2590.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
A.-M. Linko-Parvinen, R. Landberg, M. J. Tikkanen, H. Adlercreutz, and J. L. Penalvo
Alkylresorcinols from Whole-Grain Wheat and Rye Are Transported in Human Plasma Lipoproteins
J. Nutr., May 1, 2007; 137(5): 1137 - 1142.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
I. E. J. Milder, A. Kuijsten, I. C. W. Arts, E. J. M. Feskens, E. Kampman, P. C. H. Hollman, and P. Van 't Veer
Relation between Plasma Enterodiol and Enterolactone and Dietary Intake of Lignans in a Dutch Endoscopy-Based Population
J. Nutr., May 1, 2007; 137(5): 1266 - 1271.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
M. Cotterchio, B. A. Boucher, M. Manno, S. Gallinger, A. Okey, and P. Harper
Dietary Phytoestrogen Intake Is Associated with Reduced Colorectal Cancer Risk
J. Nutr., December 1, 2006; 136(12): 3046 - 3053.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
A. Kilkkinen, I. Erlund, M. J. Virtanen, G. Alfthan, K. Ariniemi, and J. Virtamo
Serum Enterolactone Concentration and the Risk of Coronary Heart Disease in a Case-Cohort Study of Finnish Male Smokers
Am. J. Epidemiol., April 15, 2006; 163(8): 687 - 693.
[Abstract] [Full Text] [PDF]


Home page
Appl. Environ. Microbiol.Home page
T. Clavel, G. Henderson, C.-A. Alpert, C. Philippe, L. Rigottier-Gois, J. Dore, and M. Blaut
Intestinal Bacterial Communities That Produce Active Estrogen-Like Compounds Enterodiol and Enterolactone in Humans
Appl. Envir. Microbiol., October 1, 2005; 71(10): 6077 - 6085.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. Stuedal, I. T. Gram, Y. Bremnes, H. Adlercreutz, M. B. Veierod, and G. Ursin
Plasma Levels of Enterolactone and Percentage Mammographic Density among Postmenopausal Women
Cancer Epidemiol. Biomarkers Prev., September 1, 2005; 14(9): 2154 - 2159.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
A. Kuijsten, I. C. W. Arts, T. B. Vree, and P. C. H. Hollman
Pharmacokinetics of Enterolignans in Healthy Men and Women Consuming a Single Dose of Secoisolariciresinol Diglucoside
J. Nutr., April 1, 2005; 135(4): 795 - 801.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. Olsen, K. E. B. Knudsen, B. L. Thomsen, S. Loft, C. Stripp, K. Overvad, S. Moller, and A. Tjonneland
Plasma Enterolactone and Breast Cancer Incidence by Estrogen Receptor Status
Cancer Epidemiol. Biomarkers Prev., December 1, 2004; 13(12): 2084 - 2089.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
N. F. Johnsen, H. Hausner, A. Olsen, I. Tetens, J. Christensen, K. E. B. Knudsen, K. Overvad, and A. Tjonneland
Intake of Whole Grains and Vegetables Determines the Plasma Enterolactone Concentration of Danish Women
J. Nutr., October 1, 2004; 134(10): 2691 - 2697.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
A. N. Begum, C. Nicolle, I. Mila, C. Lapierre, K. Nagano, K. Fukushima, S.-M. Heinonen, H. Adlercreutz, C. Remesy, and A. Scalbert
Dietary Lignins Are Precursors of Mammalian Lignans in Rats
J. Nutr., January 1, 2004; 134(1): 120 - 127.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
A. Kilkkinen, J. Virtamo, M. J. Virtanen, H. Adlercreutz, D. Albanes, and P. Pietinen
Serum Enterolactone Concentration Is Not Associated with Prostate Cancer Risk in a Nested Case-Control Study
Cancer Epidemiol. Biomarkers Prev., November 1, 2003; 12(11): 1209 - 1212.
[Abstract] [Full Text]


Home page
J. Nutr.Home page
A. Kilkkinen, L. M. Valsta, J. Virtamo, K. Stumpf, H. Adlercreutz, and P. Pietinen
Intake of Lignans Is Associated with Serum Enterolactone Concentration in Finnish Men and Women
J. Nutr., June 1, 2003; 133(6): 1830 - 1833.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
M. Vanharanta, S. Voutilainen, T. H. Rissanen, H. Adlercreutz, and J. T. Salonen
Risk of Cardiovascular Disease-Related and All-Cause Death According to Serum Concentrations of Enterolactone: Kuopio Ischaemic Heart Disease Risk Factor Study
Arch Intern Med, May 12, 2003; 163(9): 1099 - 1104.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
G. H McIntosh, M. Noakes, P. J Royle, and P. R Foster
Whole-grain rye and wheat foods and markers of bowel health in overweight middle-aged men
Am. J. Clinical Nutrition, April 1, 2003; 77(4): 967 - 974.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
K. Stumpf and H. Adlercreutz
Short-Term Variations in Enterolactone in Serum, 24-Hour Urine, and Spot Urine and Relationship with Enterolactone Concentrations
Clin. Chem., January 1, 2003; 49(1): 178 - 181.
[Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
Q. Dai, A. A. Franke, F. Jin, X.-O. Shu, J. R. Hebert, L. J. Custer, J. Cheng, Y.-T. Gao, and W. Zheng
Urinary Excretion of Phytoestrogens and Risk of Breast Cancer among Chinese Women in Shanghai
Cancer Epidemiol. Biomarkers Prev., September 1, 2002; 11(9): 815 - 821.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
L. K. Boker, Y. T. Van der Schouw, M. J. J. De Kleijn, P. F. Jacques, D. E. Grobbee, and P. H. M. Peeters
Intake of Dietary Phytoestrogens by Dutch Women
J. Nutr., June 1, 2002; 132(6): 1319 - 1328.
[Abstract] [Full Text] [PDF]


Home page
Am J EpidemiolHome page
A. Kilkkinen, P. Pietinen, T. Klaukka, J. Virtamo, P. Korhonen, and H. Adlercreutz
Use of Oral Antimicrobials Decreases Serum Enterolactone Concentration
Am. J. Epidemiol., March 1, 2002; 155(5): 472 - 477.
[Abstract] [Full Text] [PDF]


Home page
Cancer Epidemiol. Biomarkers Prev.Home page
N. K. Horner, A. R. Kristal, J. Prunty, H. E. Skor, J. D. Potter, and J. W. Lampe
Dietary Determinants of Plasma Enterolactone
Cancer Epidemiol. Biomarkers Prev., January 1, 2002; 11(1): 121 - 126.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2001 by The American Society for Nutrition